Sudeep Pharma IPO Subscription Status
Sudeep Pharma IPO subscribed over 93.71x on its last day till 5.00 PM on November 25, 2025.
- Sudeep Pharma IPO subscription QIB investors’ portion is 213.08 times, while NII subscribed 116.71 times, and RII investors subscribed 15.63 times.
- The company has received bids for 99,00,86,575 shares against 1,05,64,927 shares on offer on the last day of subscription
- Sudeep Pharma IPO subscribed over 93.71x on its day 3.
- Sudeep Pharma IPO subscribed over 5.11x on day 2.
- Sudeep Pharma IPO subscribed over 1.43x on day 1.
About Sudeep Pharma Company
Sudeep Pharma Limited, founded in 1989, is one of the leading manufacturers of excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries. They aim to support the global healthcare ecosystem by serving their product to over 100 countries and supplying more than 200 products. To support innovation in their work, they use their own in-house technologies for encapsulation, spray drying, granulation, trituration, liposomal preparations, and mixing.
Their business is basically structured into 2 verticals: 1) Pharmaceutical, food, and nutrition, which includes key mineral salts such as calcium, zinc, iron, potassium, magnesium, sodium, and copper, and 2) Specialty Ingredients includes micronutrient premixes, encapsulated ingredients, granulated minerals, and triturated blends. Moreover, Sudeep Pharma runs six manufacturing facilities with a total production capacity of 50,000 MT.
Sudeep Pharma IPO GMP:
Sudeep Pharma’s IPO GMP was ₹85 as of Tuesday, November 25, 2025. That indicates the IPO is trading at ₹678 with a ₹85 premium in the grey market against the issue price of ₹593.
